世界の短腸症候群用治療薬市場

【英語タイトル】Global Short Bowel Syndrome (SBS) Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Globalinforesearchが出版した調査資料(RG-B18737)・商品コード:RG-B18737
・発行会社(調査会社):Globalinforesearch
・発行日:2021年3月(※2024年版があります。お問い合わせください)
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate License(法人閲覧用)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

The Short Bowel Syndrome (SBS) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Short Bowel Syndrome (SBS) Drugs size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Short Bowel Syndrome (SBS) Drugs market size is expected to grow at a CAGR of xx for the next five years.

Market segmentation
Short Bowel Syndrome (SBS) Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
 Glucagon-Like Peptide-2 (GLP-2)
 Growth Hormone
 Glutamine
 Others

Market segment by Application, can be divided into
 Hospitals
 Clinics
 Retail Pharmacies

Market segment by players, this report covers
 Takeda
 Ardelyx
 Merck
 Naia Pharmaceuticals
 Nutrinia
 OxThera
 Zealand Pharma

Market segment by regions, regional analysis covers
 North America (United States, Canada, and Mexico)
 Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
 Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
 South America (Brazil, Argentina, Rest of South America)
 Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

【レポートの目次】

1 Market Overview
1.1 Product Overview and Scope of Short Bowel Syndrome (SBS) Drugs
1.2 Classification of Short Bowel Syndrome (SBS) Drugs by Type
1.2.1 Overview: Global Short Bowel Syndrome (SBS) Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type in 2020
1.2.3 Glucagon-Like Peptide-2 (GLP-2)
1.2.4 Growth Hormone
1.2.5 Glutamine
1.2.6 Others
1.3 Global Short Bowel Syndrome (SBS) Drugs Market by Application
1.3.1 Overview: Global Short Bowel Syndrome (SBS) Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Retail Pharmacies
1.4 Global Short Bowel Syndrome (SBS) Drugs Market Size & Forecast
1.5 Global Short Bowel Syndrome (SBS) Drugs Market Size and Forecast by Region
1.5.1 Global Short Bowel Syndrome (SBS) Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Short Bowel Syndrome (SBS) Drugs Market Size by Region, (2016-2021)
1.5.3 North America Short Bowel Syndrome (SBS) Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Short Bowel Syndrome (SBS) Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Short Bowel Syndrome (SBS) Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Short Bowel Syndrome (SBS) Drugs Market Drivers
1.6.2 Short Bowel Syndrome (SBS) Drugs Market Restraints
1.6.3 Short Bowel Syndrome (SBS) Drugs Trends Analysis
2 Company Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Short Bowel Syndrome (SBS) Drugs Product and Solutions
2.1.4 Takeda Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Takeda Recent Developments and Future Plans
2.2 Ardelyx
2.2.1 Ardelyx Details
2.2.2 Ardelyx Major Business
2.2.3 Ardelyx Short Bowel Syndrome (SBS) Drugs Product and Solutions
2.2.4 Ardelyx Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Ardelyx Recent Developments and Future Plans
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Short Bowel Syndrome (SBS) Drugs Product and Solutions
2.3.4 Merck Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Merck Recent Developments and Future Plans
2.4 Naia Pharmaceuticals
2.4.1 Naia Pharmaceuticals Details
2.4.2 Naia Pharmaceuticals Major Business
2.4.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product and Solutions
2.4.4 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Naia Pharmaceuticals Recent Developments and Future Plans
2.5 Nutrinia
2.5.1 Nutrinia Details
2.5.2 Nutrinia Major Business
2.5.3 Nutrinia Short Bowel Syndrome (SBS) Drugs Product and Solutions
2.5.4 Nutrinia Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Nutrinia Recent Developments and Future Plans
2.6 OxThera
2.6.1 OxThera Details
2.6.2 OxThera Major Business
2.6.3 OxThera Short Bowel Syndrome (SBS) Drugs Product and Solutions
2.6.4 OxThera Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 OxThera Recent Developments and Future Plans
2.7 Zealand Pharma
2.7.1 Zealand Pharma Details
2.7.2 Zealand Pharma Major Business
2.7.3 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product and Solutions
2.7.4 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Zealand Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Short Bowel Syndrome (SBS) Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Short Bowel Syndrome (SBS) Drugs Players Market Share
3.2.2 Top 10 Short Bowel Syndrome (SBS) Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Short Bowel Syndrome (SBS) Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Short Bowel Syndrome (SBS) Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Application (2016-2021)
5.2 Short Bowel Syndrome (SBS) Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Short Bowel Syndrome (SBS) Drugs Revenue by Type (2016-2026)
6.2 North America Short Bowel Syndrome (SBS) Drugs Revenue by Application (2016-2026)
6.3 North America Short Bowel Syndrome (SBS) Drugs Market Size by Country
6.3.1 North America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2016-2026)
6.3.2 United States Short Bowel Syndrome (SBS) Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Short Bowel Syndrome (SBS) Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Short Bowel Syndrome (SBS) Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Short Bowel Syndrome (SBS) Drugs Revenue by Type (2016-2026)
7.2 Europe Short Bowel Syndrome (SBS) Drugs Revenue by Application (2016-2021)
7.3 Europe Short Bowel Syndrome (SBS) Drugs Market Size by Country
7.3.1 Europe Short Bowel Syndrome (SBS) Drugs Revenue by Country (2016-2026)
7.3.2 Germany Short Bowel Syndrome (SBS) Drugs Market Size and Forecast (2016-2026)
7.3.3 France Short Bowel Syndrome (SBS) Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Short Bowel Syndrome (SBS) Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Short Bowel Syndrome (SBS) Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Short Bowel Syndrome (SBS) Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Application (2016-2021)
8.3 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Market Size by Region
8.3.1 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Region (2016-2026)
8.3.2 China Short Bowel Syndrome (SBS) Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Short Bowel Syndrome (SBS) Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Short Bowel Syndrome (SBS) Drugs Market Size and Forecast (2016-2026)
8.3.5 India Short Bowel Syndrome (SBS) Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Short Bowel Syndrome (SBS) Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Short Bowel Syndrome (SBS) Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Short Bowel Syndrome (SBS) Drugs Revenue by Type (2016-2021)
9.2 South America Short Bowel Syndrome (SBS) Drugs Revenue by Application (2016-2021)
9.3 South America Short Bowel Syndrome (SBS) Drugs Market Size by Country
9.3.1 South America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Short Bowel Syndrome (SBS) Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Short Bowel Syndrome (SBS) Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Revenue by Type (2016-2021)
10.2 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Revenue by Application (2016-2021)
10.3 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Market Size by Country
10.3.1 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Short Bowel Syndrome (SBS) Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Short Bowel Syndrome (SBS) Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Short Bowel Syndrome (SBS) Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer



★調査レポート[世界の短腸症候群用治療薬市場] (コード:RG-B18737)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の短腸症候群用治療薬市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆